Shandong Provincial Third Hospital

Running trials

• Recruiting

  Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

  NCT07587099· Source

• Recruiting

  Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD)

  NCT07073066· Source

• Recruiting

  Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma

  NCT06932068· Phase 2· Source

• Recruiting

  First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

  NCT06730373· Phase 2· Source

• Recruiting

  The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

  NCT04728516· Phase 4· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease2 recruiting
• Gastric and esophageal cancer2 recruiting
• Alzheimer disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  NCT06282575· Phase 3· Source

• Completed

  Photodynamic Therapy for Cholangiocarcinoma

  NCT04860154· Source